ZURICH (Reuters) - Novartis's foray into digital technology intensified on Wednesday as the Swiss drugmaker launched a mobile-phone based app to help collect data from people participating in eye disease studies.
from Reuters: Health News https://ift.tt/2HYnrFC
via IFTTT
from Reuters: Health News https://ift.tt/2HYnrFC
via IFTTT
Post a Comment